Author

I Man

Observed names: I. Man, I. Mán

OpenAlex ID: A5113995163

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39

Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O. Abani, A. Abbas, et al. · EClinicalMedicine · 5

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases

EP-1810: Zebrafish embryo model for testing potential radioprotective agent

2014 · E.R. Szabo, I. Plangár, et al. · Radiotherapy and Oncology

Ep-1579 Study on Ionizing Radiation on Vertebrate Model Using Wild Type and Transgenic Zebrafish Embryos

2012 · E.R. Szabo, I. Man, et al. · Radiotherapy and Oncology

[Atherogenic implications in obesity and diabetes mellitus in children].

1984 · I Popa, M Drăgan, et al. · PubMed

Works count: 8

Citation count: 97

H-index: 4

I10-index: 3